“Today, the Department of Justice acted to restore its solemn duty to seek, obtain, and implement lawful capital ...
Henlius (02696.HK) announced that a Phase 2/3 clinical trial of its self-developed pimurutamab HLX07 (recombinant anti-EGFR ...